LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 5057

Search options

  1. Article ; Online: Green Light Promoted Iridium(III)/Copper(I)-Catalyzed Addition of Alkynes to Aziridinoquinoxalines Through the Intermediacy of Azomethine Ylides.

    Zhelavskyi, Oleksii / Parikh, Seren / Jhang, Yin-Jia / Staples, Richard J / Zimmerman, Paul M / Nagorny, Pavel

    Angewandte Chemie (International ed. in English)

    2024  Volume 63, Issue 12, Page(s) e202318876

    Abstract: This manuscript describes the development of alkyne addition to the aziridine moiety of aziridinoquinoxalines using dual Ir(III)/Cu(I) catalytic system under green light-emitting diode (LED) photolysis ( ... ...

    Abstract This manuscript describes the development of alkyne addition to the aziridine moiety of aziridinoquinoxalines using dual Ir(III)/Cu(I) catalytic system under green light-emitting diode (LED) photolysis (λ
    Language English
    Publishing date 2024-02-12
    Publishing country Germany
    Document type Journal Article
    ZDB-ID 2011836-3
    ISSN 1521-3773 ; 1433-7851
    ISSN (online) 1521-3773
    ISSN 1433-7851
    DOI 10.1002/anie.202318876
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Conformational Sampling over Transition-Metal-Catalyzed Reaction Pathways: Toward Revealing Atroposelectivity.

    Kammeraad, Joshua A / Das, Soumik / Argüelles, Alonso J / Sayyed, Fareed Bhasha / Zimmerman, Paul M

    Organic letters

    2024  Volume 26, Issue 14, Page(s) 2867–2871

    Abstract: The Py-Conformational-Sampling (PyCoSa) technique is introduced as a systematic computational means to sample the configurational space of transition-metal-catalyzed stereoselective reactions. When applied to atroposelective Suzuki-Miyaura coupling to ... ...

    Abstract The Py-Conformational-Sampling (PyCoSa) technique is introduced as a systematic computational means to sample the configurational space of transition-metal-catalyzed stereoselective reactions. When applied to atroposelective Suzuki-Miyaura coupling to create axially chiral biaryl products, the results show a range of mechanistic possibilities that include multiple low-energy channels through which C-C bonds can be formed.
    Language English
    Publishing date 2024-01-19
    Publishing country United States
    Document type Journal Article
    ISSN 1523-7052
    ISSN (online) 1523-7052
    DOI 10.1021/acs.orglett.3c04047
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: Frontline Perspectives on Buprenorphine for the Management of Chronic Pain.

    Adler, Jeremy / Mallick-Searle, Theresa / Garofoli, Mark / Zimmerman, Amanda

    Journal of multidisciplinary healthcare

    2024  Volume 17, Page(s) 1375–1383

    Abstract: Due to the prevalence of chronic pain and high-impact chronic pain in the US, a significant percentage of the population is prescribed opioids for pain management. However, opioid use disorder is associated with reduced quality of life, along with fatal ... ...

    Abstract Due to the prevalence of chronic pain and high-impact chronic pain in the US, a significant percentage of the population is prescribed opioids for pain management. However, opioid use disorder is associated with reduced quality of life, along with fatal opioid overdoses, and is a significant burden on the US economy. Considering the clinical needs of patients with intractable chronic pain and the potential harms associated with prescribed and illicit opioids in our communities, having a deep understanding of current treatment options, supporting evidence, and clinical practice guidelines is essential for optimizing treatment selections. Buprenorphine is a Schedule III opioid with a unique mechanism of action, allowing effective and long-lasting analgesia at microgram doses with fewer negative side effects and adverse events, including respiratory depression, when compared with other immediate-release, long-acting, and extended-release prescription opioids. Due to its relatively lower risk for overdose and misuse, buprenorphine was recently added to the Clinical Practice Guideline for the Use of Opioids in the Management of Chronic Pain as a first-line treatment for chronic pain managed by opioids by the US Departments of Defense and Veterans Affairs, and the Department of Health and Human Services recommends that buprenorphine be made available for the treatment of chronic pain. In this narrative review, we discuss the different buprenorphine formulations, clinical efficacy, advantages for older adults and other special populations, clinical practice guideline recommendations, and payer considerations of buprenorphine and suggest that buprenorphine products approved for chronic pain should be considered as a first-line treatment for this indication.
    Language English
    Publishing date 2024-03-27
    Publishing country New Zealand
    Document type Journal Article ; Review
    ZDB-ID 2453343-9
    ISSN 1178-2390
    ISSN 1178-2390
    DOI 10.2147/JMDH.S449748
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Epilepsy Incidence and Developmental Outcomes After Early Discontinuation of Antiseizure Medication in Neonatal Hypoxic-Ischemic Encephalopathy.

    Jagadish, Spoorthi / Czech, Theresa Marie / Zimmerman, M Bridget / Glykys, Joseph

    Pediatric neurology

    2024  Volume 153, Page(s) 48–55

    Abstract: Background: Neonatal seizures caused by hypoxic-ischemic encephalopathy (HIE) have significant morbidity and mortality. There is variability in clinical practice regarding treatment duration with antiseizure medication (ASM) after resolution of provoked ...

    Abstract Background: Neonatal seizures caused by hypoxic-ischemic encephalopathy (HIE) have significant morbidity and mortality. There is variability in clinical practice regarding treatment duration with antiseizure medication (ASM) after resolution of provoked neonatal seizures. We examined epilepsy incidence and developmental outcomes in post-HIE neonates discharged or not on ASM.
    Methods: We conducted a retrospective chart review of all HIE-admitted neonates to the University of Iowa Hospitals & Clinics neonatal intensive care unit between January 2008 and February 2021 who presented with encephalopathy, underwent therapeutic hypothermia, and developed seizures. Neonates were divided into two groups depending on whether ASM was continued or discontinued on discharge. We evaluated the incidence of epilepsy and developmental outcomes on follow-up in these two cohorts up to 12 months.
    Results: Sixty-nine neonates met the study criteria. ASM was continued on discharge in 41 neonates (59%) and discontinued before discharge in 28 (41%). At the 12-month follow-up, nine neonates (13%) had a diagnosis of epilepsy, out of which seven neonates had ASM continued on discharge (odds ratio [OR]: 2.84; 95% confidence interval [CI]: 0.48, 29.9)]. There was no statistical difference between the development of postneonatal epilepsy between the two groups (P value 0.29). There was no significant difference in developmental outcome between the two groups after adjusting for covariates like magnetic resonance imaging (MRI) brain abnormality and number of seizure days (OR: 0.68; 95% CI: 0.21, 2.22; P = 0.52).
    Conclusion: We found no significant risk of seizure recurrence by age 12 months in infants who had discontinued ASM before discharge compared with those who had continued ASM. There was no difference in developmental outcomes at the 12-month follow-up between groups after adjusting for brain MRI abnormality and the number of seizure days during admission. Our results support early discontinuation of ASM after resolution of acute provoked seizures in neonates with HIE.
    MeSH term(s) Infant, Newborn ; Infant ; Humans ; Retrospective Studies ; Hypoxia-Ischemia, Brain/drug therapy ; Hypoxia-Ischemia, Brain/epidemiology ; Hypoxia-Ischemia, Brain/diagnosis ; Incidence ; Epilepsy/therapy ; Seizures/drug therapy ; Seizures/epidemiology ; Seizures/etiology ; Hypothermia, Induced/methods ; Infant, Newborn, Diseases/therapy
    Language English
    Publishing date 2024-01-11
    Publishing country United States
    Document type Journal Article
    ZDB-ID 639164-3
    ISSN 1873-5150 ; 0887-8994
    ISSN (online) 1873-5150
    ISSN 0887-8994
    DOI 10.1016/j.pediatrneurol.2024.01.009
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: Substrate-Selective Catalysis Enabled Synthesis of Azaphilone Natural Products.

    Wang, Ye / Torma, Katherine J / Pyser, Joshua B / Zimmerman, Paul M / Narayan, Alison R H

    ACS central science

    2024  Volume 10, Issue 3, Page(s) 708–716

    Abstract: Achieving substrate-selectivity is a central element of nature's approach to synthesis. By relying on the ability of a catalyst to discriminate between components in a mixture, control can be exerted over which molecules will move forward in a synthesis. ...

    Abstract Achieving substrate-selectivity is a central element of nature's approach to synthesis. By relying on the ability of a catalyst to discriminate between components in a mixture, control can be exerted over which molecules will move forward in a synthesis. This approach can be powerful when realized but can be challenging to duplicate in the laboratory. In this work, substrate-selective catalysis is leveraged to discriminate between two intermediates that exist in equilibrium, subsequently directing the final cyclization to arrive at either the linear or angular tricyclic core common to subsets of azaphilone natural products. By using a flavin-dependent monooxygenase (FDMO) in sequence with an acyl transferase (AT), the conversion of several orcinaldehyde substrates directly to the corresponding linear tricyclic azaphilones in a single reaction vessel was achieved. Further, mechanistic studies support that a substrate equilibrium together with enzyme substrate selectivity play an import role in the selectivity of the final cyclization step. Using this strategy, five azaphilone natural products were synthesized for the first time as well as a number of unnatural derivatives thereof.
    Language English
    Publishing date 2024-02-29
    Publishing country United States
    Document type Journal Article
    ISSN 2374-7943
    ISSN 2374-7943
    DOI 10.1021/acscentsci.3c01405
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Orbital-flop transition of superfluid

    Nguyen, M D / Simon, Joshua / Scott, J W / Zimmerman, A M / Tsai, Y C Cincia / Halperin, W P

    Nature communications

    2024  Volume 15, Issue 1, Page(s) 201

    Abstract: ... ...

    Abstract Superfluid
    Language English
    Publishing date 2024-01-03
    Publishing country England
    Document type Journal Article
    ZDB-ID 2553671-0
    ISSN 2041-1723 ; 2041-1723
    ISSN (online) 2041-1723
    ISSN 2041-1723
    DOI 10.1038/s41467-023-44557-5
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Emotion regulation difficulties link trait resilience and symptoms of depression and anxiety in psychiatric outpatients.

    Diehl, Joseph M / Smoski, Moria J / Zimmerman, Mark

    Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists

    2022  Volume 34, Issue 4, Page(s) 245–253

    Abstract: Background: Despite negative associations of trait resilience with depression and anxiety symptoms, the mechanisms by which resilience may buffer against these symptoms remain underexplored. This study investigated emotion regulation difficulties as a ... ...

    Abstract Background: Despite negative associations of trait resilience with depression and anxiety symptoms, the mechanisms by which resilience may buffer against these symptoms remain underexplored. This study investigated emotion regulation difficulties as a potential link in the relationship between trait resilience and depression and anxiety severity in psychiatric outpatients (N = 353).
    Methods: Participants diagnosed with primary depression or anxiety disorders were evaluated prior to treatment initiation with the Connor-Davidson Resilience Scale, Difficulties in Emotion Regulation Scale (DERS), Clinically Useful Depression Outcome Scale (CUDOS), and Clinically Useful Anxiety Outcome Scale (CUXOS).
    Results: In the depression sample, the effect of resilience on CUDOS scores was fully mediated by total DERS scores. In the anxiety sample, the effect of resilience on CUXOS scores was partially mediated by total DERS scores. Exploratory parallel mediation analyses showed only the DERS subscale strategies had a significant effect on CUDOS scores, while only goals had a significant effect on CUXOS scores.
    Conclusions: Emotion regulation difficulties are a mediator of trait resilience in psychiatric outpatients. For patients seeking treatment for depression, difficulties with accessing emotion regulation strategies may be particularly relevant, while difficulties meeting one's goals may be most relevant for patients seeking treatment for anxiety.
    MeSH term(s) Humans ; Outpatients/psychology ; Depression/psychology ; Emotional Regulation ; Anxiety Disorders/diagnosis ; Anxiety/psychology
    Language English
    Publishing date 2022-10-25
    Publishing country United States
    Document type Journal Article
    ZDB-ID 1025337-3
    ISSN 1547-3325 ; 1040-1237
    ISSN (online) 1547-3325
    ISSN 1040-1237
    DOI 10.12788/acp.0086
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Infective Endocarditis.

    Maruncic, Ann / Zimmerman, Meghan / Glatz, Jenifer

    Pediatrics in review

    2023  Volume 44, Issue 10, Page(s) 601–603

    MeSH term(s) Humans ; Endocarditis, Bacterial/complications ; Endocarditis, Bacterial/diagnosis ; Endocarditis, Bacterial/therapy ; Endocarditis/diagnosis ; Endocarditis/therapy
    Language English
    Publishing date 2023-09-28
    Publishing country United States
    Document type Journal Article
    ZDB-ID 774515-1
    ISSN 1526-3347 ; 0191-9601
    ISSN (online) 1526-3347
    ISSN 0191-9601
    DOI 10.1542/pir.2022-005561
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: ARFID at 10 years: A Review of Medical, Nutritional and Psychological Evaluation and Management.

    Fisher, Martin / Zimmerman, Jacqueline / Bucher, Caroline / Yadlosky, Lauren

    Current gastroenterology reports

    2023  Volume 25, Issue 12, Page(s) 421–429

    Abstract: Purpose of review: Avoidant restrictive food intake disorder (ARFID) is a diagnostic term that was established 10 years ago to describe those patients with an eating disorder, mostly children and adolescents, who have poor nutrition that is not due to ... ...

    Abstract Purpose of review: Avoidant restrictive food intake disorder (ARFID) is a diagnostic term that was established 10 years ago to describe those patients with an eating disorder, mostly children and adolescents, who have poor nutrition that is not due to body image or weight concerns. This article reviews the diagnosis and subtypes of ARFID, as well as the medical, nutritional and psychological principles of evaluation and management of the disorder.
    Recent findings: In the past 10 years, clinicians have refined their approaches to managing the two major subtypes of ARFID: (1) those patients with a longer-term restriction in the amount and/or variety of the foods they eat, and (2) those patients with a shorter-term decrease in eating because of fear of aversive consequences such as vomiting, choking, GI symptoms or an allergic reaction to food. In that same time, the field of psychology has been developing evidence-based approaches to management of ARFID in each of its manifestations. Each patient with ARFID presents with a unique set of medical, nutritional and psychological factors that requires an individualized and multi-disciplinary approach in the management of this difficult to treat disorder.
    MeSH term(s) Child ; Adolescent ; Humans ; Avoidant Restrictive Food Intake Disorder ; Feeding and Eating Disorders/diagnosis ; Feeding and Eating Disorders/therapy ; Malnutrition ; Fear ; Retrospective Studies
    Language English
    Publishing date 2023-09-27
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 2041376-2
    ISSN 1534-312X ; 1522-8037
    ISSN (online) 1534-312X
    ISSN 1522-8037
    DOI 10.1007/s11894-023-00900-w
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: It could happen again

    Anne Zimmerman

    Voices in Bioethics, Vol

    2020  Volume 6

    Abstract: ... World Health Organization, The Lancet Vol 365 March 19, 2005, and Marmot M, Allen J. Social determinants of health equity ... Am J Public Health. 2014;104 Suppl 4: S517–S519. doi:10.2105/AJPH.2014.302200 [14] Institute ...

    Abstract Cardiovascular disease, diabetes, obesity, chronic respiratory disease, hypertension, and cancer all correlate to higher mortality rates from COVID-19. The UK has also added pregnancy, neurologic diseases, and kidney and liver conditions and asserts that those with organ transplants, blood cancers, and kidney disease requiring dialysis are at even higher risk.[1] Initiatives to improve health outcomes during future pandemics must include a long-term plan to reduce preventable diseases that are likely to contribute to death and severity of future novel respiratory viruses. Policies that promote or fail to reduce widespread health challenges in the US should be changed in response to the current pandemic. While better preparation, access to test kits, quarantining, contact tracing, vaccines, and new anti-viral medicines are all understandable immediate priorities, a healthier population would fare better. It is the government’s ethical duty to support health initiatives that address the social determinants of health. Such initiatives include paid sick leave, ending subsidies for unhealthy foods, and implementation of federal workplace requirements that ensure workers have breaks, stress relief tools, and wages sufficient to purchase healthy foods, safe housing, and health insurance. Government policy can alleviate stress by expanding healthcare coverage for those living paycheck to paycheck and by taking measures to alleviate poverty. Early mortality data from China presented by the World Health Organization from February 2020 indicate the devastation of preexisting conditions. Below are data for preexisting conditions followed by death rate for confirmed cases and death rate for all cases: • Cardiovascular disease / 13.2% / 10.5% • Diabetes / 9.2% / 7.3% • Chronic respiratory disease / 8.0% / 6.3% • Hypertension / 8.4% / 6.0% • Cancer / 7.6% / 5.6% • no pre-existing conditions 0.9% *Death Rate = (number of deaths / number of cases) = probability of dying if infected by the virus (%). The percentages do not have to add up to 100%, as they do NOT represent share of deaths by condition.[2] Currently, all countries collecting COVID-19 data are reporting higher death rates for those with preexisting conditions. One hospital in New Jersey expressed surprise that younger patients are coming in with severe cases. “Dr. Adam Jarrett, the center's chief medical officer, told NBC News on Monday, adding he was surprised patients' ages skewed younger than he'd expected. All but one had underlying health conditions, such as heart or lung disease, diabetes and obesity.” Jarrett specifically noted the impact of obesity on lung capacity.[3] Data from Italy implies that obesity is a major risk factor.[4] According to the American Heart Association, approximately 168.1 million people (71.1 percent of the US population) are obese or overweight.[5] The CDC estimates 42 percent of people are obese. 9.2 percent of adults are severely obese.[6] The CDC estimates one in every four people with diabetes does not know they have it. 100 million people have either diabetes or prediabetes, while 9.8 percent of the population have confirmed cases of diabetes.[7] In a study evaluating an array of respiratory viruses including influenza and coronavirus, researchers concluded the obese and morbidly obese have more hospital stays and more severe illness.[8] The UK is warning that those with body mass index >40 are most at risk.[9] Obesity causes both cardiovascular disease and high blood pressure, increasing the odds of one person having several preexisting conditions when a novel virus appears. Solving the obesity crisis would also reduce the incidence of heart disease, hypertension, some cancers, and some liver and kidney problems. High blood pressure is prevalent in the US population. 116.4 million people have it[10] and the stress of the pandemic itself may cause more cases. In addition to high blood pressure, some blood pressure medications such as angiotensin-converting enzyme (ACE) inhibitors may contribute to the severity of Italy’s coronavirus cases.[11] In China, almost a quarter of the population has hypertension and an additional forty percent show signs of early stage hypertension.[12] Whether the underlying condition or the medications are the source of the more severe cases, decreasing the incidence of high blood pressure could decrease the impact of future novel viruses. The World Health Organization in its Social Determinants of Health recommend policies, habits, and conditions that promote good health. WHO advocates proven ways to prevent or reduce obesity, stress related diseases, and cardiovascular problems.[13] In the short term, the experts might be right to identify the comorbidity without attempting to remedy it. For now, scarce resources are devoted to urgent cases of the coronavirus. People at risk should use extra caution, practice social distancing and isolation, and follow suggested guidelines for hand hygiene. In the long term, the US must investigate the habits that create the comorbidity. The next big pandemic may have the same characteristics. SARS and MERS were both respiratory coronaviruses with characteristics similar to COVID-19. People with obesity, high blood pressure, and heart disease would likely do worse than those without preexisting conditions regardless of the specifics of a future pandemic. If COVID-19 continues to spread and remains devoid of reliable treatments, there is no evidence that it is too late to cure a preexisting condition even within a few months. The influenza of 1918 had a virulent second wave.[14] If COVID-19 mutates or persists longer than expected, improving people’s basic health wherever possible should be a priority. Weight loss and gradual exercise improvements can stave off diabetes, decrease blood pressure, and prevent strokes and heart disease. Those on the verge of diabetes or cardiovascular issues may improve their outcome by changing habits now with the support of public policy. With comorbidity prevention in mind as well as socially-conscious strategies to address the next novel virus, public policy will lessen the severity and mortality of future novel viruses. March 26, 2020 [1] Sharma, Sonia. “From pregnant to obese - List of those most at risk from coronavirus.” Chronicle Live UK. March 17, 2020. https://www.chroniclelive.co.uk/news/north-east-news/coronavirus-most-at-risk-pregnant-17936541 [2] https://www.worldometers.info/coronavirus/coronavirus-age-sex-demographics/ based on both: The Report of the WHO-China Joint Mission published on Feb. 28 by WHO, which is based on 55,924 laboratory confirmed cases. The report notes that “The Joint Mission acknowledges the known challenges and biases of reporting crude CFR early in an epidemic" (see also a paper by the Chinese CCDC released on Feb. 17, which is based on 72,314 confirmed, suspected, and asymptomatic cases of COVID-19 in China as of Feb. 11, and was published in the Chinese Journal of Epidemiology.) [3] Edwards, Erika. “Not just older people: Younger adults are also getting the coronavirus Simply looking at the age ranges of the infected, however, doesn't provide any insights into the severity of the illness.” NBC News. March 17, 2020. https://www.nbcnews.com/health/health-news/not-just-older-people-younger-adults-are-also-getting-coronavirus-n1160416 [4] O’Regan, Eilish. “From risks due to obesity to how children are affected: coronavirus lessons from front-line medics.” Independent.ie. March 18, 2020. https://www.independent.ie/world-news/coronavirus/from-risks-due-to-obesity-to-how-children-are-affected-coronavirus-lessons-from-front-line-medics-39054089.html [5]American Heart Association. https://www.ahajournals.org/doi/10.1161/CIR.0000000000000757 [6] Hales CM, Carroll MD, Fryar CD, Ogden CL. Prevalence of obesity and severe obesity among adults: United States, 2017–2018. NCHS Data Brief, no 360. Hyattsville, MD: National Center for Health Statistics. 2020 https://www.cdc.gov/nchs/products/databriefs/db360.htm [7] https://www.cdc.gov/media/releases/2017/p0718-diabetes-report.html [8] Moser JS, Galindo-Fraga A, Ortiz-Hernández AA, et al. Underweight, overweight, and obesity as independent risk factors for hospitalization in adults and children from influenza and other respiratory viruses. Influenza Other Respir Viruses. 2019;13(1):3–9. doi:10.1111/irv.12618 finding “In adults with coronavirus, metapneumovirus, parainfluenza, and rhinovirus, participants that were underweight (OR: 4.07) and morbidly obese (OR: 2.78) were more likely to be hospitalized as compared to normal‐weight adults.” [9] https://www.mirror.co.uk/news/uk-news/coronavirus-severely-obese-warned-among-21704686 [10]American Heart Association. https://www.ahajournals.org/doi/10.1161/CIR.0000000000000757 [11] Fang, Lei, George Karakiulakis, and Michael Roth, “Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?” The Lancet March 11, 2020 DOI:https://doi.org/10.1016/S2213-2600(20)30116-8 https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(20)30116-8/fulltext [12] Minter, Adam, “To Treat Pandemics, Start by Treating Hypertension: Controlling common ailments is the first step for low- and middle-income countries looking ahead to what comes after the coronavirus crisis.” Bloomberg News. March 19, 2020. https://www.bloomberg.com/opinion/articles/2020-03-19/high-blood-pressure-is-risk-for-countries-after-coronavirus-ends [13] Wilkinson, Richard and Michael Marmot, World Health Organization, Social Determinants of Health, The Solid Facts. (2003). Updated and explained by Marmot in “The Social Determinants of Health Inequities” World Health Organization, The Lancet Vol 365 March 19, 2005, and Marmot M, Allen J. Social determinants of health equity. Am J Public Health. 2014;104 Suppl 4: S517–S519. doi:10.2105/AJPH.2014.302200 [14] Institute of Medicine (US) Forum on Microbial Threats; Knobler SL, Mack A, Mahmoud A, et al., editors. The Threat of Pandemic Influenza: Are We Ready? Workshop Summary. Washington (DC): National Academies Press (US); 2005. 1, The Story of Influenza. Available from: https://www.ncbi.nlm.nih.gov/books/NBK22148/
    Keywords comorbidity ; COVID-19 ; preexisting conditions ; ethics ; bioethics ; Medical philosophy. Medical ethics ; R723-726 ; BJ1-1725 ; covid19
    Subject code 300
    Language English
    Publishing date 2020-03-01T00:00:00Z
    Publisher Columbia University Libraries
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

To top